Zun-Yi Wang Selected Research

Zun-Yi Wang Research Topics

Disease

12	Cystitis 04/2015 - 01/2006
11	Inflammation (Inflammations) 04/2015 - 01/2006
6	Hyperalgesia 01/2015 - 07/2008
5	Pain (Aches) 01/2018 - 10/2011
4	Neoplasms (Cancer) 01/2020 - 12/2004
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2020
2	Visceral Pain 01/2018 - 09/2008
2	Edema (Dropsy) 01/2015 - 04/2014
1	Hypoxia (Hypoxemia) 01/2020
1	Carcinogenesis 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 12/2019
1	Nociceptive Pain 01/2018
1	Urinary Bladder Diseases (Bladder Diseases) 04/2014
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 06/2011
1	Urologic Diseases (Urinary Tract Disease) 06/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2008
1	Transitional Cell Carcinoma 03/2008
1	Hypersensitivity (Allergy) 01/2006
1	Corneal Neovascularization 12/2004
1	Necrosis 12/2004
1	Ganglion Cysts (Ganglion) 01/2002

Drug/Important Bio-Agent (IBA)

8	Acrolein (Aqualin)IBA 01/2015 - 06/2007
6	Nerve Growth Factor (NGF)IBA 03/2015 - 01/2006
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2015 - 01/2006
3	Proteins (Proteins, Gene)FDA Link 10/2009 - 12/2004
2	Messenger RNA (mRNA)IBA 01/2020 - 03/2008
2	EnzymesIBA 01/2018 - 10/2011
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 04/2015 - 10/2011
2	CannabinoidsIBA 04/2015 - 09/2013
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2014 - 05/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2009 - 09/2008
2	staurosporine aglycone (K252a)IBA 07/2008 - 01/2006
1	Phosphotransferases (Kinase)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Untranslated RNA (Noncoding RNA)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 12/2019
1	fibrin fragment D (D-dimer)IBA 12/2019
1	AlbuminsIBA 12/2019
1	C-Reactive ProteinIBA 12/2019
1	EndocannabinoidsIBA 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	arachidonyl-2-chloroethylamideIBA 01/2015
1	iodopravadoline (AM 630)IBA 04/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2013
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2011
1	anandamide (arachidonylethanolamide)IBA 10/2011
1	Interleukin-6 (Interleukin 6)IBA 06/2011
1	LipopolysaccharidesIBA 06/2011
1	Tryptases (Tryptase)IBA 10/2009
1	Peptide Hydrolases (Proteases)FDA Link 10/2009
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2009
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2008
1	Indicators and Reagents (Reagents)IBA 09/2008
1	Bradykinin Receptors (Bradykinin Receptor)IBA 09/2008
1	Nerve Growth Factors (Neurotrophins)IBA 07/2008
1	PlasticsIBA 07/2008
1	Estrogen Receptor betaIBA 03/2008
1	Estrogens (Estrogen)FDA Link 03/2008
1	Cyclin EIBA 03/2008
1	Cyclin D1IBA 03/2008
1	Estrogen Receptor alphaIBA 03/2008
1	4-trifluoromethylsalicylic acid (HTB)IBA 03/2008
1	Toll-Like Receptor 4IBA 02/2008
1	Interleukin-12 (IL 12)IBA 12/2004
1	LigandsIBA 12/2004
1	InterleukinsIBA 12/2004
1	Integrin alphaVbeta3IBA 12/2004
1	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 12/2004
1	Peptides (Polypeptides)IBA 12/2004
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2002
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2002

Therapy/Procedure

8	Intravesical Administration 04/2014 - 06/2007
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2020
1	Microspheres (Microsphere) 01/2020
1	Radiotherapy 01/2020
1	Therapeutics 01/2018
1	Analgesia 09/2013
1	Intraperitoneal Injections 01/2006